Sourcing raw material from donors is a crucial element when establishing autologous and allogeneic cell and gene therapy programs. If your program isn’t using a robust, reliable/recallable, and well-characterized donor pool to obtain this material, you could be spending more time and money trying to find the appropriate donors and adding extra variability and stress to your program.
During this webinar, we highlight how a large, diverse donor pool gives researchers access to project-specific physiological or demographic traits, how reliable and recallable donors reduce variability and can facilitate the development of project-specific, dedicated donor pools, and how dedicated donors ensure researchers have continued access to consistent starting material from donors who meet project-specific criteria long-term.
Kimberly Negrin, PhD
Associate Sales Director, Cell Therapy
HemaCare, a Charles River company
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.